Medella Therapeutics Overview

  • Founded
  • 2005
Founded
  • Status
  • Out of Business
  • Employees
  • 6
Employees
  • Latest Deal Type
  • Out of Business

Medella Therapeutics General Information

Description

Developer of monoclonal antibody drugs for the treatment of pancreatic cancer. The company's monoclonal antibody drugs interferes with the cell signalling activities of receptor activity modifying proteins and stops the growth of tumour, enabling healthcare institutes to treat a range of diseases including bone disease, cancer, cardiovascular disease, inflammation, neurological function and obesity.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Primary Office
  • The Sheffield Bioincubator
  • 40 Leavygreave Road
  • Sheffield S3 7RD
  • England, United Kingdom
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Medella Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Out of Business 01-Jan-2017 Completed Out of Business
2. Buyout/LBO 01-Jan-2007 00000 00.000 Completed Startup
1. Grant 01-Jan-2005 Completed Startup
To view Medella Therapeutics’s complete valuation and funding history, request access »

Medella Therapeutics Executive Team (2)

Name Title Board Seat Contact Info
Keith Wreggett Ph.D Managing Director
Tim Skerry Board Member, Chief Scientific Officer & Co-Founder
To view Medella Therapeutics’s complete executive team members history, request access »

Medella Therapeutics Board Members (3)

Name Representing Role Since
Tim Skerry Medella Therapeutics Board Member, Chief Scientific Officer & Co-Founder 000 0000
To view Medella Therapeutics’s complete board members history, request access »

Medella Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial